Show simple item record

dc.contributor.authorVan Cutsem, E
dc.contributor.authorBang, Y
dc.contributor.authorMansoor, Was
dc.contributor.authorPetty, R
dc.contributor.authorChao, Y
dc.contributor.authorCunningham, D
dc.contributor.authorFerry, D
dc.contributor.authorSmith, N
dc.contributor.authorFrewer, P
dc.contributor.authorRatnayake, J
dc.contributor.authorStockman, P
dc.contributor.authorKilgour, E
dc.contributor.authorLanders, D
dc.date.accessioned2017-07-26T13:49:05Z
dc.date.available2017-07-26T13:49:05Z
dc.date.issued2017-06
dc.identifier.citationA randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification 2017, 28 (6):1316 Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdx107
dc.identifier.urihttp://hdl.handle.net/10541/620458
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdx107en
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleA randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUnit of Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgiumen
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2018-12-17T15:01:09Z


Files in this item

Thumbnail
Name:
mdx107.pdf
Size:
620.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record